Source: Google NewsPublished on 2022-06-20
Related Articles:
- Analysis of the Effect of Dopamine Transporter Scan on the Diagnosis and Management in a Tertiary Neurology Center. June 28, 2019 Analysis of the Effect of Dopamine Transporter Scan on the Diagnosis and Management in a Tertiary Neurology Center. Neurohospitalist. 2019 Jul;9(3):144-150 Authors: Bhattacharjee S, Paramanandam V, Bhattacharya A Abstract Background and Purpose: The dopamine transporter scan or DaT scan is abnormal in presynaptic parkinsonism but normal in nondegenerative or postsynaptic parkinsonism. In this study, we tried to ascertain the impact…
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Scientists Developing “Game-Changing” Test to Diagnose Parkinson’s Based on Compounds Found on Skin - SciTechDaily March 15, 2021 Scientists Developing “Game-Changing” Test to Diagnose Parkinson’s Based on Compounds Found on Skin SciTechDaily
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- “Quick, simple and painless”: a new way to diagnose Parkinson’s disease? March 18, 2021 A new technique developed by UK scientists may help doctors diagnose Parkinson’s disease “quickly and accurately” using compounds found on the skin’s surface In a survey of more than 2,000 people, conducted by charity Parkinson’s UK, 26% reported that they were misdiagnosed with a different condition before being correctly diagnosed with Parkinson’s disease. Now, a new technique developed by scientists…
- DBS: location, location, location December 15, 2019 Deep brain stimulation (or DBS) represents a well established treatment option for individuals with Parkinson’s who no longer respond to standard therapies. It involves tiny electrodes being embedded in the brain and they modulate populations of neurons that have become dysfunctional. The results of the DBS procedure can be “miraculous” for some individuals – reducing tremors and significantly improving…
- Monthly research review: February 2020 February 29, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
- Saying goodbye to Man’s (Twitchy Woman’s) Best Friend March 9, 2019 We said goodbye to our dog Lucy this morning. This is the fourth dog that we have lost, and it never gets any easier to say goodbye. As a friend said to me, dog’s are God’s joke on men. They are man’s best friend, but their lives are way too short. From the start, she was my dog. Lucy…
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease February 11, 2022 Clin Park Relat Disord. 2022 Jan 7;6:100130. doi: 10.1016/j.prdoa.2022.100130. eCollection 2022.ABSTRACTINTRODUCTION: Considering the difficulties of differentiating Parkinson's disease (PD) from drug-induced Parkinsonism (DIP) in patients receiving antipsychotics, developing robust diagnostic tools is essential. Herein, we used the metaiodobenzylguanidine (MIBG) scan to assess its diagnostic accuracy for this purpose.METHODS: 44 DIP patients and 32 patients with PD as controls were enrolled.…
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease February 11, 2022 Clin Park Relat Disord. 2022 Jan 7;6:100130. doi: 10.1016/j.prdoa.2022.100130. eCollection 2022.ABSTRACTINTRODUCTION: Considering the difficulties of differentiating Parkinson's disease (PD) from drug-induced Parkinsonism (DIP) in patients receiving antipsychotics, developing robust diagnostic tools is essential. Herein, we used the metaiodobenzylguanidine (MIBG) scan to assess its diagnostic accuracy for this purpose.METHODS: 44 DIP patients and 32 patients with PD as controls were enrolled.…
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease February 11, 2022 Clin Park Relat Disord. 2022 Jan 7;6:100130. doi: 10.1016/j.prdoa.2022.100130. eCollection 2022.ABSTRACTINTRODUCTION: Considering the difficulties of differentiating Parkinson's disease (PD) from drug-induced Parkinsonism (DIP) in patients receiving antipsychotics, developing robust diagnostic tools is essential. Herein, we used the metaiodobenzylguanidine (MIBG) scan to assess its diagnostic accuracy for this purpose.METHODS: 44 DIP patients and 32 patients with PD as controls were enrolled.…
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease February 11, 2022 Clin Park Relat Disord. 2022 Jan 7;6:100130. doi: 10.1016/j.prdoa.2022.100130. eCollection 2022.ABSTRACTINTRODUCTION: Considering the difficulties of differentiating Parkinson's disease (PD) from drug-induced Parkinsonism (DIP) in patients receiving antipsychotics, developing robust diagnostic tools is essential. Herein, we used the metaiodobenzylguanidine (MIBG) scan to assess its diagnostic accuracy for this purpose.METHODS: 44 DIP patients and 32 patients with PD as controls were enrolled.…
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease February 11, 2022 Clin Park Relat Disord. 2022 Jan 7;6:100130. doi: 10.1016/j.prdoa.2022.100130. eCollection 2022.ABSTRACTINTRODUCTION: Considering the difficulties of differentiating Parkinson's disease (PD) from drug-induced Parkinsonism (DIP) in patients receiving antipsychotics, developing robust diagnostic tools is essential. Herein, we used the metaiodobenzylguanidine (MIBG) scan to assess its diagnostic accuracy for this purpose.METHODS: 44 DIP patients and 32 patients with PD as controls were enrolled.…
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease February 11, 2022 Clin Park Relat Disord. 2022 Jan 7;6:100130. doi: 10.1016/j.prdoa.2022.100130. eCollection 2022.ABSTRACTINTRODUCTION: Considering the difficulties of differentiating Parkinson's disease (PD) from drug-induced Parkinsonism (DIP) in patients receiving antipsychotics, developing robust diagnostic tools is essential. Herein, we used the metaiodobenzylguanidine (MIBG) scan to assess its diagnostic accuracy for this purpose.METHODS: 44 DIP patients and 32 patients with PD as controls were enrolled.…
- FDA Approves PET Imaging Compound to Aid Early Diagnosis and Disease Monitoring January 2, 2020 The Feinstein Institutes for Medical Research announced that the U.S. Food and Drug Administration (FDA) has approved an imaging compound its researchers developed as a diagnostic tool for people with suspected parkinsonian syndromes, including Parkinson’s disease. Fluorodopa F18 (FDOPA) is an injectable compound used during a PET scan to mark the dopaminergic nerve terminals that degenerate in Parkinson’s disease. Better imaging may increase…
- Structure of a Toxic Matter Identified That Destroys the Nerves in the Brain, Causing Alzheimer's and Parkinson's Diseases - SciTechDaily May 29, 2021 Structure of a Toxic Matter Identified That Destroys the Nerves in the Brain, Causing Alzheimer's and Parkinson's Diseases SciTechDaily
- Chemists Find an Effective Remedy for “Aged” Brain Diseases Such As Alzheimer’s and Parkinson’s - SciTechDaily August 8, 2021 Chemists Find an Effective Remedy for “Aged” Brain Diseases Such As Alzheimer’s and Parkinson’s SciTechDaily
- Scientists Identify the Cause of Alzheimer’s Progression in the Brain – Very Different Than Previously Thought - SciTechDaily October 30, 2021 Scientists Identify the Cause of Alzheimer’s Progression in the Brain – Very Different Than Previously Thought SciTechDaily
- Viagra Is Promising Drug Candidate To Help Prevent and Treat Alzheimer’s Disease - SciTechDaily December 6, 2021 Viagra Is Promising Drug Candidate To Help Prevent and Treat Alzheimer’s Disease SciTechDaily
- Future Large Scale Testing for Alzheimer's: New Technology Unveils the Mysteries of the Disease - SciTechDaily June 11, 2022 Future Large Scale Testing for Alzheimer's: New Technology Unveils the Mysteries of the Disease SciTechDaily
- Experimental Antibodies for Parkinson’s and Alzheimer’s May Cause Harmful Inflammation - SciTechDaily April 18, 2021 Experimental Antibodies for Parkinson’s and Alzheimer’s May Cause Harmful Inflammation SciTechDaily